PremiumCompany AnnouncementsNeuroScientific Biopharmaceuticals Issues New Securities Under Section 708A Neuroscientific Biopharmaceuticals Issues New Equity Securities Neuroscientific Biopharmaceuticals Announces Issuance of Performance Shares PremiumCompany AnnouncementsNeuroScientific’s StemSmart Therapy Shows Promise in Treating Severe GVHD Neuroscientific Biopharmaceuticals Announces Cessation of Securities Neuroscientific Biopharmaceuticals Announces New Securities Placement PremiumCompany AnnouncementsNeuroScientific Biopharmaceuticals Expands with New Acquisitions and Research Initiatives Neuroscientific Biopharmaceuticals Announces Proposed Securities Issue NeuroScientific Biopharmaceuticals Expands into Stem Cell Therapy with StemSmart Acquisition